SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+7.96%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.32B
AUM Growth
+$1.32B
(+9.9%)
Cap. Flow
+$196M
Cap. Flow
% of AUM
14.83%
Top 10 Holdings %
Top 10 Hldgs %
42.53%
Holding
111
New
24
Increased
21
Reduced
23
Closed
30
Top Buys
| 1 |
NovoCure
NVCR
|
$81.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$65.8M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$46.1M |
| 4 |
Integra LifeSciences
IART
|
$28.9M |
| 5 |
AstraZeneca
AZN
|
$26.8M |
Top Sells
| 1 |
Sanofi
SNY
|
$35.3M |
| 2 |
IDEAYA Biosciences
IDYA
|
$33.2M |
| 3 |
Revolution Medicines
RVMD
|
$22M |
| 4 |
10x Genomics
TXG
|
$21.5M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$15.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NARI
101
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-93,878
| Closed | -$3.87M |
|
|
LBPH
102
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – |
-318,269
| Closed | -$10.6M |
|
|
103
Sanofi
SNY
$121B
| – | – |
-612,000
| Closed | -$35.3M |
|
104
Natera
NTRA
$23.1B
| – | – |
-29,900
| Closed | -$3.8M |
|
105
Olema Pharmaceuticals
OLMA
$375M
| – | – |
-103,500
| Closed | -$1.24M |
|
106
Insulet
PODD
$23.9B
| – | – |
-16,750
| Closed | -$3.9M |
|
107
Relay Therapeutics
RLAY
$619M
| – | – |
-910,000
| Closed | -$6.44M |
|
|
SLN
108
Silence Therapeutics
SLN
$227M
| – | – |
-260,000
| Closed | -$4.73M |
|
109
AbbVie
ABBV
$372B
| – | – |
-15,750
| Closed | -$3.11M |
|
110
Alector
ALEC
$238M
| – | – |
-1,207,371
| Closed | -$5.63M |
|
111
Applied Therapeutics
APLT
$71M
| – | – |
-680,784
| Closed | -$5.79M |
|